Abstract
Introduction
Congenital heart disease (CHD) is the most frequent type of congenital malformation with a relative incidence of 6/1000 live births and a small percentage of this CHD is related to chromosomal abnormality described in literature (1, 2) . An important cause of mortality and morbidity is represented by the malformation itself and by the complications which may occur in the long term (3, 4) . In the majority of these cases the etiology remains unknown, but among the known causes of congenital heart disease, approximately one third of cases is associated with genetic factors such as chromosomal anomalies identified in about 0.4 -26.8% of all CHD, copy number variants (CNVs), gene mutations (5) (6) (7) (8) . Based on the findings reported by Pânzaru et al in a study that included 1123 children with multiple congenital anomalies of which 321 patients had CHD, the frequency of chromosomal aberrations varied by type of CHD and was higher in patients with atrioventricular canal (AVC), persistent ductus arteriosus (PDA), ventricular and atrial septal defects (VSD, ASD) (9) .
Chromosomal aberrations consisting of CNVs, like microduplication or microdeletion, are described as a major cause in the etiology of CHD, with a mean value of 14% in syndromic CNVs and 7% in non-syndromic CNVs (5, 10, 11) . In addition, Karen et al. classified the CNVs as follow: the first type are CNVs correlated with microdeletion syndromes, from which we can highlight those associated with CHD (like DiGeorge or William's syndromes) or due to chromosomal rearrangements, chromosomal mosaicism or partial aneuploidy; the second type are CNVs that contain genes involved in embryogenesis of the heart development (GATA4); and in the third category the CNVs described to be correlated with a variety of other phenotypes (12) . Microdeletions/ microduplications in patients with intellectual disability syndrome; intellectual disability associated with dysmorphic features and/ or multiple congenital abnormalities may be detected by using fluorescence in situ hybridization (FISH) and Multiplex Ligation-dependent Probe Amplification (MLPA) (13) .
Recently, the introduction and use of microarray technology has led to the identification of numerous syndromes with microdeletions and microduplications by submicroscopic detection of CNVs with unprecedented resolution, now in patients with intellectual disability and/ or multiple congenital anomalies, microarray test or whole exome sequencing may be considered as a first-tier diagnostic test (14) . However, this new technology requires consumables that are hardly accessible to all diagnostic centers and of course, expensive equipment (15) .
Despite modern cytogenetics and significant advances in molecular-genetic technologies such as FISH and comparative genomic hybridization (CGH), karyotyping and MLPA technique continue to be a crucial and basic tool in genetic evaluation, even for developing countries.
Here, we present the importance of classical cytogenetic methods in the diagnosis procedure in one case with multiple congenital anomalies and intellectual disability and the impact of MLPA technique for CNVs analysis in confirma- 
Material and methods

Clinical report
We investigated a patient referred to the Genetic department in January 2018, at the age of one and a half years old, born at term after an imminent abortion during the second semester of pregnancy with healthy parents (26-year-old mother and 27-year-old father) and unrelated. He is the first child in the family born by cesarean section delivery, with a birth weight of 2200g. After birth, the neonate was submitted to a surgical intervention for cleft lip and palate. He was diagnosed with an atrial septal defect accusing an effort intolerance and profuse sweating. Echocardiography revealed a large atrial septal defect (ASD) and scrotal ultrasound show bilateral high undescended testicles. Neurological evaluation highlighted a hypotonic syndrome with a retard in psychomotor development because he did not sit unsupported, but kept rolling front to back and was walking with support. Dysmorphological examination showed microcephaly, downslanting palpebral fissures, long lashes, thick eyebrows, protruding nose with wide base, long philtrum, downturned corners of the mouth and microretrognathia. Taking into account the patient's clinical phenotype, cytogenetic testing was recommended.
Cytogenetic Analysis
Cytogenetic analysis was performed form peripheral blood lymphocytes, cultures were stimulated with phytohemagglutinin and were carried out according to the standard protocol using air dropping technique. G-banding with standard staining at a 400-500 band level was performed according to ISCN 2013. The patient karyotype disclosed a numerical aberration 47,XY,+mar and the small sSMC was considered to be a fragment of chromosome 22. Considering the clinical characteristics of our patient and karyotyping analysis we raised the suspicion of Emanuel syndrome. The karyotyping analysis was recommended for parents but to date they have postponed the investigation.
Multiplex Ligation Dependent Probe Amplification
Following the cytogenetic results, genomic DNA was extracted from peripheral blood leukocytes using iPrep PureLink gDNA Blood Kit (Invitrogen, Carlsbad, CA, USA) in the iPrep purification instrument.
In addition to cytogenetic analyses, we performed MLPA for investigation of the most common copy number changes associated with microdeletion and microduplication syndromes that include intellectual disability, CHD, etc. The MLPA (MRC Holland, Amsterdam, Holland) analysis was performed, in the first step, using commercial kit for exons located at the chromosome 22, namely SALSA MLPA P064 Microdeletion Syndrome-1B probemix from MRC-Holland (Amsterdam, Netherlands) and all the abnormalities identified by this kit were confirmed using syndrome-specific MLPA kits. All the procedures (DNA denaturation, hybridization reaction, ligation reaction, PCR reaction, fragment separation by capillary electrophoresis) were performed according to the manufacturer's protocol.
Fragments were analyzed by capillary electrophoresis using the Applied Biosystems 3500 Genetic Analyzer with a 50 cm array using POP-7 polymer. Result analyses were achieved using the Coffalyser.Net software. The number of copies for region of interest were calculated using final ratio; the normal corresponded value was between 0.7 and 1.3.
Ethics committee approval for genetic testing was obtained from the Ethics Committee of the University of Medicine and Pharmacy of Tîr-gu Mureș, Romania.
Results
The MLPA analysis using SALSA MLPA probemix P064-C2 Microdeletion Syndromes-1B revealed a large duplication for the region 22q11.1 -q11.23, containing the genes: CLTCL1 exon 3, CDC45 exon 1 and DGCR8 exon 2 ( Figure 1 ).
According to Product Description SALSA MLPA probemix P064-C2 Microdeletion Syndromes-1B the results must be confirmed by another independent technique. Considering the result of karyotyping that highlights the presence of sSMC derivative and other studies which use a combination of MLPA kits in detection of chromosomal abnormalities we performed another analysis using the kit as follows: SALSA MLPA probemix P311-B1 Congenital Heart Disease and SALSA MLPA probemix P250-B2 DiGeorge (11, 16) . The P311 probemix contains probe for the following genes GATA4, NKX2-5, TBX5, BMP4, CRELD1 involved in normal heart development, and this kit (Figure 2) .
MLPA probemix P250-B2 DiGeorge that include probes for 22q11. 4, SLC25A18 exon 1, BID exon 4, MICAL3 exon 20, USP18 exon 1, CLTCL1 exon 3, HIRA exon 25, CDC45 exon 1, CLDN5 exon 1, GP1BB exon 2, TBX1 exon 2, TBX1 exon 7, TXNRD2 exon 9, DGCR8 exon 2, ZNF74 exon 2, KLHL22 exon 2, MED15 exon 10, SNAP29 exon 5, LZTR1 exon 16, HIC2 exon 2, PPIL2 exon 20, TOP3B exon 7, RTDR1 exon 6, GNAZ exon 3, RTDR1 exon 2, RAB36 exon 1, SMARCB1 exon 1 and SMARCB1 exon 9). According to the phenotype, confirmation of 22q11.2 region duplication, confirmation by facial recognition by using Face-to-Gene (https://www.face2gene.com/) and description made by Zou et al. and Liehr the final diagnosis was Emanuel syndrome or the so-called "derivative chromosome 22 syndrome". Emanuel syndrome is frequently caused as a translocation between chromosome 22q11.2 and 11q23 present in one of the parents (17, 18) . For complementary investigation, for subtelomeric 11q region we performed an additional MLPA analysis using MLPA probemix P036-E3 Subtelomeres Mix 1 and P070 Subtelomeres Mix 2B considering the recommendation of the MRC Holland to use both MLPA probemix P036 and P070 for testing because all P070 probes are different from P036 kit.
MLPA probemix P036-E3 Subtelomeres Mix 1 content 2 probes for each subtelomeric region, except for acrocentric chromosomes (13, 14, 15, 21, 22) are recommended for primary screening of subtelomeres. The results with increased signal intensity and final ratio > 1.3 indicate a heterozygous duplication of gene NCAPD3 exon 2 located in 11.q25 region (Figure 3A) . SALSA MLPA P070 Subtelomeres Mix 2B probemix that contains probes for 11q25 for gene IGSF9B and also for 22q11.1 IL17RA exon 4, and we noticed a duplication in both implicated regions from 11q25 and 22q11.1 ( Figure 3B) .
CNVs detected by P036 or P070 must be verified by a designated MLPA follow-up probe- mix. In this regard, we used SALSA MLPA probemix P286-B2 Human Telomere-11 for confirmation of the results obtained with MLPA probemix P036-E3 Subtelomeres Mix 1.
Results for SALSA MLPA probemix P286-B2 confirmed a heterozygous duplication for 11q24.3-q25 for exons of the gene analyzed in this region, as follow: NFRKB exon 4, APLP2 exon 18, NTM exon 6, OPCML exon 7, OPC-ML intr 1, SPATA19 exon 5, NCAPD3 exon 2, B3GAT1 exon 2 ( Figure 4 ).
Discussion
The first step, for primary identification in cytogenetic techniques is the karyotyping which remains a precise and feasible method especially in small supernumerary marker chromosome (sSMC) (19) . sSMC are detected in about 0.3% of cases with multiple congenital anomalies (MCA) and/or developmental delay (20, 21) . Classical karyotyping detects abnormalities in 3-15% of cases with multiple congenital malformation (22) . Often, using classical cytogenetics technique, the dimension of the sSMC does not allow accurate determination of the chromosome origin. The confirmation of the origin/ provenance of sSMC is mandatory for an accurate diagnosis. For the first step in diagnosis confirmation the whole-genome array (WGA) screening has been frequently recommended. The major disadvantage for WGA is linked to costs, followed by FISH method when it is compared with traditional karyotyping (22) .
Thus, the MLPA is a viable alternative because it is a low-cost usable technique, which is a rapid and sensitive determination in molecular screening for sSMC through CNVs analysis. This technique allows for quantity evaluation of up to 50 amplicons in one single reaction using a small amount of the DNA or RNA sample. It was introduced in 2002 by MRC Holland and it is currently available with 400 panels kit with a related short time to results and high sensitivity and simplicity (https://mlpa.com).
In the literature, multiple studies describe the usefulness of using a combination of MLPA kits for determining the chromosomal abnormality with a range results between 3.2-33.33% which depend on the kit that was used and the patient group selection (11, 23) .
Moreover, MLPA is able to detect the gene dosage disruption and in our case, the gene identified in duplicated region was investigated us- (24) . The CNVs duplication syndrome and gene duplication detected with P250 kit are described as associated with abnormality of the nervous system, abnormality of the head or neck, and abnormality of limbs (https:// mlpa.com). NCAPD3 gene located in 11.q25 region is phenotypically associated with small size for gestational age, trigonocephaly, feeding difficulties in infancy, proportionate short stature, ptosis, renal hypoplasia. In this case, the follow-up method for karyotypes which identified an sSMC was the MLPA technique, a successful method to establish the chromosomal fragments involved in the formation of sSMC. The genetic content of sSMC is involved directly in the phenotypic abnormalities. Multiple studies describe the use of WGA and FISH for sSMC but compared with these, the MLPA technique has a significant advantage such as one reaction can determine the chromosomal gene content for the unique-sequence positive sSMC, although targeted FISH is sometimes necessary to determine the structure of the sSMC and is often used following an abnormal array result (25) .
Considering the investigated case and the many kits used, karyotyping remains the gold standard in setting microscopic chromosome changes. In order to confirm the results of the karyotype, MLPA is an advantage especially due to the possibility of detecting duplications and deletions of a single exon from a gene. Other advantages are about costs, by reducing them, short processing time, and increased specificity through the possibility of confirmation with other kits.
According to our clinical case, the utility of these techniques has been major. Firstly, by confirming the presence of a supernumerary chromosome marker derived from chromosome 22 by highlighting genes at this level, and secondly, the possibility of identifying the presence of a duplication of a region in chromosome 11, therefore MLPA analysis revealed a microduplication at 11q25 and 22q11.1. As such, the patient presents partial trisomy for genes located in 11q25 and 22q region. The duplicated genes revealed by MLPA analysis and previously published cases of Emanuel syndrome are phenotypically similar to our patient (2) . In this case, the genetic techniques used confirm our clinical diagnosis and allow for a proper genetic counseling regarding the risks of recurrence.
We concluded that the association of CHD represented by ASD, developmental delay, hypotonic syndrome, dysmorphic features are caused by the microduplication of chromosome 11 and 22, based on our CNVs analysis performed.
In conclusion, we consider that MLPA is a useful, fast and cost-effective method for identification of small supernumerary marker chromosome in children with developmental delay and congenital heart defect. Genetic diagnosis using different molecular techniques for increasing the accuracy in identification of chromosomal structural aberrations has an important role in the genetic counseling and our case explains the importance of using a specific laboratory technique for each stage of the diagnosis. final manuscript. FT performed DNA isolation, MLPA analysis and interpreted the results, read and approved the manuscript. AB performed cytogenetic analyses, and MLPA analysis and read and approved the manuscript. AF collected blood sample, performed ultrasound investigation, read and approved the manuscript. CB designed the study, interpreted the results, read the draft of the manuscript, revised it critically and approved the final version of manuscript.
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